protocolApplied
The protocol (set of recommendations) being followed by the provider who administered the dose.
doseNumberPositiveInt
Nominal position in a series of vaccines,
N.B. This field will not always be reliable, therefore for Covid vaccinations, the vaccination procedure code or situation code should be used as that includes the dose number.
It is recommended for international/EU interoperability targetDisease
is populated. The SNOMED CT concept should be from EU COVID-19 Diseases or Vaccine Target Diseases (GPS) - IPS
Disease | UK SNOMED self |
---|---|
COVID-19 | 840539006 |
Others | See "Vaccine Target Diseases (GPS) - IPS" |
Immunization.id[0] | UKCore-Immunization-Sn-ProtocolApplied-Example |
Immunization.status[0] | completed |
Immunization.vaccineCode[0].coding[0].system[0] | https://dmd.nhs.uk |
Immunization.vaccineCode[0].coding[0].code[0] | 39114911000001105 |
Immunization.vaccineCode[0].coding[0].display[0] | COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
Immunization.patient[0].reference[0] | Patient/UKCore-Patient-RichardSmith-Example |
Immunization.occurrenceDateTime[0] | 2021-07-20 |
Immunization.protocolApplied[0].targetDisease[0].coding[0].system[0] | http://snomed.info/sct |
Immunization.protocolApplied[0].targetDisease[0].coding[0].code[0] | 840539006 |
Immunization.protocolApplied[0].targetDisease[0].coding[0].display[0] | COVID-19 |
Immunization.protocolApplied[0].doseNumberPositiveInt[0] | 1 |
Immunization |
id : UKCore-Immunization-Sn-ProtocolApplied-Example |
status : completed |
vaccineCode |
coding |
system : https://dmd.nhs.uk |
code : 39114911000001105 |
display : COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
patient |
reference : Patient/UKCore-Patient-RichardSmith-Example |
occurrence : 2021-07-20 |
protocolApplied |
targetDisease |
coding |
system : http://snomed.info/sct |
code : 840539006 |
display : COVID-19 |
doseNumber : 1 |
<Immunization xmlns="http://hl7.org/fhir"> <id value="UKCore-Immunization-Sn-ProtocolApplied-Example" /> <status value="completed" /> <vaccineCode> <coding> <system value="https://dmd.nhs.uk" /> <code value="39114911000001105" /> <display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" /> </coding> </vaccineCode> <patient> <reference value="Patient/UKCore-Patient-RichardSmith-Example" /> </patient> <occurrenceDateTime value="2021-07-20" /> <!-- **************snippet start************** --> <protocolApplied> <targetDisease> <coding> <system value="http://snomed.info/sct" /> <code value="840539006" /> <display value="COVID-19" /> </coding> </targetDisease> <doseNumberPositiveInt value="1" /> </protocolApplied> <!-- **************snippet end************** --> </Immunization>
{ "resourceType": "Immunization", "id": "UKCore-Immunization-Sn-ProtocolApplied-Example", "status": "completed", "vaccineCode": { "coding": [ { "system": "https://dmd.nhs.uk", "code": "39114911000001105", "display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" } ] }, "patient": { "reference": "Patient/UKCore-Patient-RichardSmith-Example" }, "occurrenceDateTime": "2021-07-20", "protocolApplied": [ { "targetDisease": [ { "coding": [ { "system": "http://snomed.info/sct", "code": "840539006", "display": "COVID-19" } ] } ], "doseNumberPositiveInt": 1 } ] }